The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models

BACKGROUND: Interventions to protect young infants against respiratory syncytial virus (RSV) are in advanced phases of development and are expected to be available in the foreseeable future. Gavi, the Vaccine Alliance, included maternal vaccines and infant monoclonal antibodies for RSV as part of th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Vaccine
Main Authors: Baral, Ranju, Li, Xiao, Willem, Lander, Antillon, Marina, Vilajeliu, Alba, Jit, Mark, Beutels, Philippe, Pecenka, Clint
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier Science 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7342012/
https://ncbi.nlm.nih.gov/pubmed/32586761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.06.036
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares